Advertisement

Topics

GenePOC Inc Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750

09:16 EST 3 Mar 2017 | BioPortfolio Report Blog

Summary

GenePOC Inc. GenePOC is a biomedical company which specializes in development of rapid molecular devices for providing targeted therapy for infectious diseases. It offers onthespot diagnostic devices for achieving optimal patient management. The company's GenePOC Diagnostics is a portable instrument is based on a novel centripetal technology platform. Its GenePOC Diagnostics is an automated pointofcare POC molecular diagnostic system that facilitates early detection and the prevention of infectious diseases. The company's POC diagnostic system is employed in the detection of respiratory tract infections, neonatal infections, gastrointestinal tract, hospital acquired infections, sexually transmitted diseases and women's health. GenePOC is headquartered in Quebec City, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company GenePOC Inc
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Original Article: GenePOC Inc Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750

NEXT ARTICLE

More From BioPortfolio on "GenePOC Inc Product Pipeline Analysis, 2016 Update [Updated: 30122016] Prices from USD $750"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...